ANNA MALOVANNAYA to Transcription Factors
This is a "connection" page, showing publications ANNA MALOVANNAYA has written about Transcription Factors.
Connection Strength
0.329
-
Superior preclinical efficacy of co-treatment with BRG1/BRM and FLT3 inhibitor against AML cells with FLT3 mutations. Blood Cancer J. 2025 03 15; 15(1):40.
Score: 0.114
-
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor. Blood. 2024 05 16; 143(20):2059-2072.
Score: 0.108
-
Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. Mol Syst Biol. 2015 Jan 21; 11(1):775.
Score: 0.057
-
Proteome-wide profiling of activated transcription factors with a concatenated tandem array of transcription factor response elements. Proc Natl Acad Sci U S A. 2013 Apr 23; 110(17):6771-6.
Score: 0.050